Ingo Chakravarty

Ingo Chakravarty

Chief Executive Officer at Mesa Biotech, Inc.

Health Technology
Finance
Electronic Technology

Profile

Ingo Chakravarty is an Operating Partner at Northpond Ventures.
He has 30 years of experience in building, scaling and leading high-performance teams and companies in the diagnostics and precision medicine sectors.
Ingo was recently President and CEO of Mesa, which he successfully sold to Thermo Fisher Scientific in 2021.
Prior to Mesa, Ingo held multiple executive roles in the diagnostics and precision medicine sectors, including CEO of Navican Genomics, SVP and GM of GenMark Diagnostics, (acquired by Roche), VP and GM of Gen-Probe (acquired by Hologic), and various leadership roles at Ventana Medical Systems (acquired by Roche).
He received a degree in electrical engineering from the Friedrich Heacker School in Germany.

Ingo Chakravarty active positions

CompaniesPositionStart
Chief Executive Officer -
Private Equity Investor 01/05/2023
Director/Board Member 01/05/2023
All active positions of Ingo Chakravarty

Former positions of Ingo Chakravarty

CompaniesPositionEnd
Navican Genomics, Inc. Chief Executive Officer 01/11/2019
GENMARK DIAGNOSTICS, INC. Corporate Officer/Principal 07/06/2016
Corporate Officer/Principal -
Corporate Officer/Principal 31/12/2003
Corporate Officer/Principal 30/09/1996
See the detail of Ingo Chakravarty's experience

Training of Ingo Chakravarty

Friedrich Hecker School Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ingo Chakravarty's experience

Connections

63

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies8

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Finance

Navican Genomics, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Ingo Chakravarty